Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$1.85 - $2.57 $746,654 - $1.04 Million
-403,597 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$1.59 - $2.51 $154,443 - $243,806
-97,134 Reduced 19.4%
403,597 $819,000
Q4 2019

Feb 14, 2020

BUY
$1.96 - $2.81 $133,085 - $190,801
67,901 Added 15.69%
500,731 $1.29 Million
Q3 2019

Nov 14, 2019

BUY
$2.12 - $9.37 $917,599 - $4.06 Million
432,830 New
432,830 $991,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $96.9M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.